Agilent Technologies Stock News

PUNE, India, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Global Next Generation Sequencing (NGS) Market is growing with a CAGR of 17.1% in the forecast period of 2022 to 2029 and is expected to reach USD 29,307.13 Million by 2029. The most appropriate, exclusive, realistic, and admirable Next Generation Sequencing (NGS) Market Research Report is delivered with devotion depending upon the business needs. With the precise base year and the historic year, estimations and calculations are performed in this industry report. Market share analysis and key trend analysis are the key accomplishing factors in this market report. Report helps to recognize how the market is going to perform in the forecast years by giving information about market definition, classifications, applications, and engagements. DBMR team provides Next Generation Sequencing (NGS) Market research report with loyalty that is promising and the way in which expected. Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market Key Companies operating in the Next Generation Sequencing (NGS) Market are: Agilent Technologies Inc Thermo Fisher Scientific Inc QIAGEN Illumina Inc Bio-Rad Laboratories Inc Roche Sequencing (A subsidiary of F.

Test for Feed Earnings ESP

546 Tale of the Tape : Zacks Education Value Score

547 Tale of the Tape : Zacks Education Growth Score

11 Dividend Increases To Start 2022 Including A Dividend King

Agilent Technologies (A) closed at $160.65 in the latest trading session, marking a +0.92% move from the prior day.

Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Europe Molecular Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com''s offering.

Agilent Technologies, Inc. (NYSE:A) CEO Michael R. Mcmullen sold 123,459 shares of the firms stock in a transaction dated Monday, December 20th. The stock was sold at an average price of $148.82, for a total transaction of $18,373,168.38. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC []

Another factual information on the "Immunoprotein Diagnostic Testing Market" has as of late added by CMI to its storehouse. This global research report offers an inside and out examination of various perspectives, for example, global market patterns, pieces of the

DUBLIN, Dec. 23, 2021 /PRNewswire/ -- The "Cannabis Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product, Type, End User, and Portability and Geography" report has been added to ResearchAndMarkets.com''s offering. According to the study, the market is expected

Nordea Investment Management AB increased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 100.3% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 533,634 shares of the medical research company’s stock after purchasing an additional 267,275 shares during the […]

According to the report, The global Next-generation Sequencing (NGS) market size is expected to reach $38.42 Billion by 2028 growing at the CAGR of 18.14% from 2021 to 2028. The major factor driving the growth of the Next-generation Sequencing (NGS)

Whittier Trust Co. of Nevada Inc. increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 65.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,268 shares of the medical research company’s stock after purchasing an additional 503 shares during the quarter. Whittier […] The post Agilent Technologies, Inc. (NYSE:A) Stock Holdings Increased by Whittier Trust Co. of Nevada Inc. appeared first on ETF Daily News .